Page 59 - Read Online

Page 8 of 9 Sazonova et al. Vessel Plus 2019;3:5 I http://dx.doi.org/10.20517/2574-1209.2018.56

participant has signed a written informed consent to participate in this investigation.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Lu N, Zhu JX, Yang PX, Tan XR. Models for improved diagnosis of left ventricular hypertrophy based on conventional
electrocardiographic criteria. BMC Cardiovasc Disord 2017;17:217.
2. Kawai K, Sengoku H, Ishihara H, Akematsu T, Nanahoshi M, et al. Total clinical course and autopsy findings of left ventricular outflow
tract obstruction due to sigmoid septum: histologically proven isolated basal septal hypertrophy. Intern Med 2017;56:2151-4.
3. Kubo T, Kitaoka H. Imaging of left ventricular hypertrophy: a practical utility for differential diagnosis and assessment of disease
severity. Curr Cardiol Rep 2017;19:65.
4. Adhyapak SM, Menon PG, Rao Parachuri V. Improvements in left ventricular twist mechanics following myectomy for hypertrophic
cardiomyopathy with mid-ventricular obstruction. Interact Cardiovasc Thorac Surg 2017;25:128-30.
5. Markus MR, Werner N, Schipf S, Siewert-Markus U, Bahls M, et al. Changes in body weight and composition are associated with
changes in left ventricular geometry and function in the general population: SHIP (Study of Health in Pomerania). Circ Cardiovasc
Imaging 2017;10:e005544.
6. Khutan H, Aggarwal S, Kajal KS, Garg R, Kaur R, et al. Study of carotid intimal medial thickness in essential hypertension with or
without left ventricular hypertrophy. Ann Afr Med 2017;16:192-5.
7. Cansu GB, Yılmaz N, Yanıkoğlu A, Özdem S, Yıldırım AB, et al. Assessment of diastolic dysfunction, arterial stiffness, and carotid
intima-media thickness in patients with acromegaly. Endocr Pract 2017;23:536-45.
8. Ciccone MM, Scicchitano P, Zito A, Agati L, Gesualdo M, et al. Correlation between coronary artery disease severity, left ventricular
mass index and carotid intima media thickness, assessed by radio-frequency. Cardiovasc Ultrasound 2011;9:32.
9. Folsom AR, Yatsuya H, Psaty BM, Shahar E, Longstreth WT Jr. Carotid intima-media thickness, electrocardiographic left ventricular
hypertrophy, and incidence of intracerebral hemorrhage. Stroke 2011;42:3075-9.
10. Pierdomenico SD, Mancini M, Cuccurullo C, Guglielmi MD, Pierdomenico AM, et al. Prediction of carotid plaques in hypertensive
patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness. Heart Vessels 2013;28:277-83.
11. Jobe M, Kane A, Jones JC, Pessinaba S, Nkum BC, et al. Electrocardiographic left ventricular hypertrophy among gambian diabetes
mellitus patients. Ghana Med J 2015;49:19-24.
12. Rojek M, Rajzer M, Wojciechowska W, Gąsowski J, Pizoń T, et al. The relation between blood pressure components and left atrial
volume in the context of left ventricular mass index. Medicine (Baltimore) 2017;96:e9459.
13. De Jong KA, Czeczor JK, Sithara S, McEwen K, Lopaschuk GD, et al. Obesity and type 2 diabetes have additive effects on left
ventricular remodelling in normotensive patients-a cross sectional study. Cardiovasc Diabetol 2017;16:21.
14. Dörr M, Ittermann T, Aumann N, Obst A, Reffelmann T, et al. Subclinical hyperthyroidism is not associated with progression of
cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up. Clin
Endocrinol (Oxf) 2010;73:821-6.
15. Al-Daydamony MM, El-Tahlawi M. What is the effect of metabolic syndrome without hypertension on left ventricular hypertrophy?
Echocardiography 2016;33:1284-9.
16. Patel SK, Wai B, Lang CC, Levin D, Palmer CNA, et al. Genetic variation in kruppel like factor 15 is associated with left ventricular
hypertrophy in patients with type 2 diabetes: discovery and replication cohorts. Ebiomedicine 2017;18:171-8.
17. Sano M, Kamitsuji S, Kamatani N, Tabara Y, Kawaguchi T, et al. Genome-wide association study of absolute QRS voltage
identifies common variants of TBX3 as genetic determinants of left ventricular mass in a healthy Japanese population. PLoS One
2016;11:e0155550.
18. Huber M, Lezius S, Reibis R, Treszl A, Kujawinska D, et al. A single nucleotide polymorphism near the CYP17A1 gene is associated
with left ventricular mass in hypertensive patients under pharmacotherapy. Int J Mol Sci 2015;16:17456-68.
19. Xu X, Hou X, Liang Y, Li F, Pang L, et al. The gene polymorphism of LOX1 predicts the incidence of LVH in patients with essential
hypertension. Cell Physiol Biochem 2014;33:88-96.
20. Boon-Peng H, Mat Jusoh JA, Marshall CR, Majid F, Danuri N, et al. Rare copy number variants identified suggest the regulating
pathways in hypertension-related left ventricular hypertrophy. PLoS One 2016;11:e0148755.
21. Zhu HY, Wang SW, Liu L, Li YH, Chen R, et al. A mitochondrial mutation A4401G is involved in the pathogenesis of left ventricular
hypertrophy in Chinese hypertensives. Eur J Hum Genet 2009;17:172-8.
22. Govindaraj P, Khan NA, Rani B, Rani DS, Selvaraj P, et al. Mitochondrial DNA variations associated with hypertrophic
cardiomyopathy. Mitochondrion 2014;16:65-72.
23. Bates MG, Hollingsworth KG, Newman JH, Jakovljevic DG, Blamire AM, et al. Concentric hypertrophic remodelling and